Early Predictors of Mortality in Patients with COPD, in Relation to Respiratory and Non-Respiratory Causes of Death – A National Register Study

References

• SorianoJB, AbajobirAA, Hassen AbateK, et al. for GBD 2015 chronic respiratory disease collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the global burden of disease study 2015. Lancet Respir Med. 2017;5(9):691–706.28822787
   PubMed Web of Science ®Google Scholar
• PapaioannouAI, LoukidesS, GourgoulianisKI, KostikasK. Global assessment of the COPD patient: time to look beyond FEV1? Respir Med. 2009;103(5):650–660. doi:10.1016/j.rmed.2009.01.00119167871
   PubMed Web of Science ®Google Scholar
• CelliBR. Predictors of mortality in COPD. Respir Med. 2010;104(6):773–779. doi:10.1016/j.rmed.2009.12.01720417082
   PubMed Web of Science ®Google Scholar
• MotegiT, JonesRC, IshiiT, et al. A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations. Int J Chron Obstruct Pulmon Dis. 2013;8:259–271. doi:10.2147/COPD.S4276923754870
   PubMed Web of Science ®Google Scholar
• ErogluSA, GunenH, YakarHI, YildizE, KavasM, DumanD. Influence of comorbidities in long-term survival of chronic obstructive pulmonary disease patients. J Thorac Dis. 2019;11(4):1379–1386. doi:10.21037/jtd.2019.03.7831179080
   PubMed Web of Science ®Google Scholar
• CelliBR, CoteCG, LareauSC, MeekPM. Predictors of Survival in COPD: more than just the FEV1. Respir Med. 2008;102(Suppl 1):S27–S35. doi:10.1016/S0954-6111(08)70005-218582794
   PubMed Web of Science ®Google Scholar
• OngKC, EarnestA, LuSJ. A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest. 2005;128(6):3810–3816. doi:10.1378/chest.128.6.381016354849
   PubMed Web of Science ®Google Scholar
• Soler-CatalunaJJ, Martinez-GarciaMA, SanchezLS, TorderaMP, SanchezPR. Severe exacerbations and BODE index: two independent risk factors for death in male COPD patients. Respir Med. 2009;103(5):692–699. doi:10.1016/j.rmed.2008.12.00519131231
   PubMed Web of Science ®Google Scholar
• CelliBR, CoteCG, MarinJM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi:10.1056/NEJMoa02132214999112
   PubMed Web of Science ®Google Scholar
• de TorresJP, CasanovaC, MarinJM, et al. Prognostic evaluation of COPD patients: GOLD 2011 versus BODE and the COPD comorbidity index COTE. Thorax. 2014;69(9):799–804. doi:10.1136/thoraxjnl-2014-20577024969641
   PubMed Web of Science ®Google Scholar
• CoteCG, Pinto-PlataVM, MarinJM, NekachH, DordellyLJ, CelliBR. The modified BODE index: validation with mortality in COPD. Eur Respir J. 2008;32(5):1269–1274. doi:10.1183/09031936.0013850718579541
   PubMed Web of Science ®Google Scholar
• OgaT, TsukinoM, HajiroT, IkedaA, NishimuraK. Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:521–526. doi:10.2147/COPD.S2442022069363
   PubMed Web of Science ®Google Scholar
• SundhJ, JansonC, LisspersK, StallbergB, MontgomeryS. The Dyspnoea, Obstruction, Smoking, Exacerbation (DOSE) index is predictive of mortality in COPD. Primary Care Respir j. 2012;21(3):295–301. doi:10.4104/pcrj.2012.0005422786813
   PubMedGoogle Scholar
• PuhanMA, Garcia-AymerichJ, FreyM, et al. Expansion of the prognostic assessment of patients with chronic obstructive pulmonary disease: the updated BODE index and the ADO index. Lancet. 2009;374(9691):704–711. doi:10.1016/S0140-6736(09)61301-519716962
   PubMed Web of Science ®Google Scholar
• MarinJM, AlfagemeI, AlmagroP, et al. Multicomponent indices to predict survival in COPD: the COCOMICS study. Eur Respir J. 2013;42(2):323–332. doi:10.1183/09031936.0012101223222874
   PubMed Web of Science ®Google Scholar
• Abu HusseinN, Ter RietG, SchoenenbergerL, et al. The ADO index as a predictor of two-year mortality in general practice-based chronic obstructive pulmonary disease cohorts. Respiration. 2014;88(3):208–214. doi:10.1159/00036377025115178
   PubMed Web of Science ®Google Scholar
• PuhanMA, HanselNN, SobradilloP, et al. Large-scale international validation of the ADO index in subjects with COPD: an individual subject data analysis of 10 cohorts. BMJ Open. 2012;2(6):e002152. doi:10.1136/bmjopen-2012-002152
   PubMed Web of Science ®Google Scholar
• BestallJC, PaulEA, GarrodR, GarnhamR, JonesPW, WedzichaJA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.58110377201
   PubMed Web of Science ®Google Scholar
• JonesPW, HardingG, BerryP, WiklundI, ChenWH, Kline LeidyN. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.0010250919720809
   PubMed Web of Science ®Google Scholar
• BeckerC, SchaferJ, CarvalhoLL, VitielloIP, da SilvaAL. CAT correlates positively with respiratory rate and is a significant predictor of the impact of COPD on daily life of patients: a cross sectional study. Multidiscip Respir Med. 2014;9(1):47. doi:10.1186/2049-6958-9-4725485107
   PubMedGoogle Scholar
• WHO. International Classification of Diseases (ICD); 2010 Available from: https://icd.who.int/browse10/2019/en. Accessed 35, 2020.
   Google Scholar
• MaltaisF, DennisN, ChanCK. Rationale for earlier treatment in COPD: a systematic review of published literature in mild-to-moderate COPD. COPD. 2013;10(1):79–103. doi:10.3109/15412555.2012.71904823272663
   PubMedGoogle Scholar
• AlmagroP, CalboE, Ochoa de EchaguenA, et al. Mortality after hospitalization for COPD. Chest. 2002;121(5):1441–1448. doi:10.1378/chest.121.5.144112006426
   PubMed Web of Science ®Google Scholar
• EstebanC, QuintanaJM, AburtoM, et al. Predictors of mortality in patients with stable COPD. J Gen Intern Med. 2008;23(11):1829–1834. doi:10.1007/s11606-008-0783-x18795373
   PubMed Web of Science ®Google Scholar
• Garcia-SanzMT, Canive-GomezJC, Senin-RialL, et al. One-year and long-term mortality in patients hospitalized for chronic obstructive pulmonary disease. J Thorac Dis. 2017;9(3):636–645. doi:10.21037/jtd.2017.03.3428449471
   PubMed Web of Science ®Google Scholar
• KaszubaE, OdebergH, RastamL, HallingA. Impact of heart failure and other comorbidities on mortality in patients with chronic obstructive pulmonary disease: a register-based, prospective cohort study. BMC Fam Pract. 2018;19(1):178. doi:10.1186/s12875-018-0865-830474547
   PubMed Web of Science ®Google Scholar
• PrudenteR, FrancoEAT, MesquitaCB, FerrariR, de GodoyI, TanniSE. Predictors of mortality in patients with COPD after 9 years. Int J Chron Obstruct Pulmon Dis. 2018;13:3389–3398. doi:10.2147/COPD.S17466530410324
   PubMed Web of Science ®Google Scholar
• de VoogdJN, WempeJB, KoeterGH, et al. Depressive symptoms as predictors of mortality in patients with COPD. Chest. 2009;135(3):619–625. doi:10.1378/chest.08-007819029432
   PubMed Web of Science ®Google Scholar
• SinDD, AnthonisenNR, SorianoJB, AgustiAG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi:10.1183/09031936.0013380517138679
   PubMed Web of Science ®Google Scholar
• GelbergJ, McIvorRA. Overcoming gaps in the management of chronic obstructive pulmonary disease in older patients: new insights. Drugs Aging. 2010;27(5):367–375. doi:10.2165/11535220-000000000-0000020450235
   PubMed Web of Science ®Google Scholar
• FanerR, NoellG, Ramon BadiaJ, López-GiraldoA, BakkeP, SilvermanEK. Distribution, temporal stability and association with all-cause mortality of the 2017 GOLD groups in the ECLIPSE cohort. Respir Med. 2018;141:14–19. doi:10.1016/j.rmed.2018.06.01530053959
   PubMed Web of Science ®Google Scholar
• ÇolakY, AfzalS, MarottJL, et al. Prognosis of COPD depends on severity of exacerbation history: a population-based analysis. Respir Med. 2019;155:141–147. doi:10.1016/j.rmed.2019.07.02131362177
   PubMed Web of Science ®Google Scholar
• PesolaGR, AhsanH. Dyspnea as an independent predictor of mortality. Clin Respir J. 2016;10(2):142–152. doi:10.1111/crj.1219125070878
   PubMed Web of Science ®Google Scholar
• AhmedT, StewardJA, O’MahonyMS. Dyspnoea and mortality in older people in the community: a 10-year follow-up. Age Ageing. 2012;41(4):545–549. doi:10.1093/ageing/afs04922522776
   PubMed Web of Science ®Google Scholar
• McCarthyB, CaseyD, DevaneD, MurphyK, MurphyE, LacasseY. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:CD003793. doi:10.1002/14651858.CD003793
   PubMed Web of Science ®Google Scholar
• ManWD, ChowdhuryF, TaylorRS, et al. Building consensus for provision of breathlessness rehabilitation for patients with chronic obstructive pulmonary disease and chronic heart failure. Chron Respir Dis. 2016;13(3):229–239. doi:10.1177/147997231664236327072018
   PubMed Web of Science ®Google Scholar
• BohlinI. Evidence-based desicion-making in a scientific society. About the evidence movement’s origin, dispersion and limits. [Swedish: evidensbaserat beslutsfattande i ett vetenskapligt samhälle. Om evidensrörelsens ursprung, utbredning och gränser] In: BohlinI, SagerM, editors. The Many Faces of the Evidence. Evidence-Based Practice in Practice. [Swedish: Evidensens Många Ansikten. Evidensbaserad Praktik I Praktiken]. Lund: Arkiv förlag; 2011:31–68.
   Google Scholar